Davol Inc.

Davol Inc., a division of Becton, Dickinson and Company (BD), manufactures and supplies surgical mesh implants, soft tissue reconstruction products, and related medical devices to the Department of Veterans Affairs and other federal healthcare agencies as a prime contractor on full-and-open competitive awards, holding no small business designations.

Davol operates as a large business entity competing without set-aside protections across a portfolio of 4,665 prime awards and 101 sub-awards spanning nearly five decades of federal contracting. The company's concrete capability centers on hernia repair meshes (PHASIX, PHASIX ST, XENMATRIX, and BARD-branded variants), abdominal wall reconstruction solutions, xenograft products, stents, and blood pressure monitors—devices procured by VA medical centers on an as-needed basis through delivery orders and purchase orders. Recent representative prime awards include a $32.2 million delivery order from Veterans Integrated Service Network 19 in June 2026 for mesh implant products with performance in Salt Lake City, Utah; a $47.9 million delivery order from VISN 23 in October 2025 for PHASIX MESH 10X12; and a $71.4 million delivery order from VISN 15 in May 2025 for mesh inserts. Davol anchors its federal presence on a $52.6 million single-award indefinite delivery contract with VA Headquarters for "SURGICAL IMPLANT NEXT GENERATION" products running through September 2028, supplemented by blanket purchase agreements across multiple VISNs and a BPA with VISN 2 for BARD PHASIX meshes extending through June 2027.

Customer concentration sits overwhelmingly with the Department of Veterans Affairs across its integrated service networks. The top five customer entities by award count account for roughly 10% of Davol's total award portfolio: VISN 7 leads with 132 awards valued at $1.3 million, followed by VISN 12 (109 awards, $995 thousand), VISN 10 (99 awards, $4.3 million), Defense Logistics Agency (80 awards), and VISN 2 (78 awards, $704 thousand). When ranked by potential value rather than award frequency, the Department of the Army Medical Command rises to prominence with 41 awards worth $6.2 million, but VA network facilities remain the dominant customer base. This concentration reflects Davol's strategic positioning as a just-in-time surgical implant supplier to the VA's nationwide healthcare infrastructure.

Davol's award portfolio is heavily weighted toward prime work—98% of recent awards are prime contracts, IDVs, and purchases rather than sub-awards. The company places task orders under the Biologics and Biological Implants indefinite delivery contract (28 task orders, $734 thousand combined value), along with multiple agency-specific IDIQs including SPE2DM20D2004 (28 task orders), contract 36C10G23D0064 (17 task orders, $466 thousand), and SPE2DM20D9001 (16 task orders). Federal Supply Schedule V797P4316A carries 15 task orders with minimal combined value.

Activity has remained relatively flat in recent years—38 awards in 2022, 35 in 2023, 40 in 2024, and 30 in 2025, with only one award recorded in 2026 (the June delivery order to VISN 19). The vendor faces minimal near-term recompete pressure; only one award with an ultimate completion date within the next twenty-four months carries $32 thousand in potential value. The broader portfolio carries combined potential value of $2.19 billion against $23.5 million in combined obligated dollars, indicating that most awards remain unexecuted or partially executed in the source snapshot.

In its subcontractor role, Davol supplies surgical mesh products and medical devices to Cardinal Health 200, LLC on numerous sub-awards for medical and surgical equipment spanning from 2021 through late 2025. These sub-awards focus on Davol's core mesh offerings—PHASIX variants, PHASIX ECHO 2 configurations, PHASIX ST rectangular formats, and related surgical instrumentation—distributed across Cardinal Health's federal supply channels.

Award NAICS coding reflects Davol's manufacturing and distribution footprint: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (1,009 awards), Surgical Appliance and Supplies Manufacturing (570 awards), Electromedical and Electrotherapeutic Apparatus Manufacturing (204 awards), and Surgical and Medical Instrument Manufacturing (167 awards). Primary PSC coding aligns to Medical and Surgical Instruments, Equipment, and Supplies (4,189 awards). Davol maintains facilities in Warwick, Rhode Island, where most purchase orders are fulfilled, with performance locations spanning VA medical centers nationwide.